12/05/2014 - 10:15am

Greenstone announced the introduction of cabergoline tablets to its line of pharmaceutical products.

 

12/04/2014 - 2:12pm

Camber Pharmaceuticals announced the addition of montelukast sodium tablets to its portfolio of products.

12/04/2014 - 1:10pm

Mylan on Thursday announced that its subsidiary, Mylan Labs, was granted tentative approval from the Food and Drug Administration for two dosages of abacavir/lamivudine tablets for oral suspension. 

11/24/2014 - 9:52am

Dr. Reddy's Labs on Monday announced the launch of docetaxel injection USP in 20-mg and 80-mg dosage strengths. The drug is the generic version of Taxotere.

 

11/20/2014 - 1:06pm

Amneal Pharmaceuticals on Thursday announced the launch of Lopreeza (estradiol/norethindrone acetate) tablets in 0.5-mg and 1-mg dosage strengths. The product is the first authorized generic of Activella from Novo Nordisk.

 

11/20/2014 - 10:42am

Dr. Reddy’s Labs announced Thursday that it has launched a bioequivalent generic version of Allegra-D 12 Hour Allergy and Congestion, in the U.S. market.

11/19/2014 - 4:32am

Reynolds American on Thursday will be sharing information on the national launch of Zonnic, a smoking cessation gum marketed by the company's subsidiary Niconovum USA.

11/18/2014 - 2:28pm

Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries, on Tuesday announced that Health Canada has approved its application for PrTeva-Celecoxib, the generic equivalent of PrCelebrex.

11/17/2014 - 9:54am

Genzyme, a Sanofi company, on Friday announced that the Food and Drug Administration approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis.